Evidence map›Paper›PMID 34223159›Full record

ReviewRSC medicinal chemistry2021

Recent developments on MOF-based platforms for antibacterial therapy.

Yiwei Liu, Luyi Zhou, Ying Dong, Rui Wang, Ying Pan, Shuze Zhuang, Dong Liu, Jianqiang Liu

Abstract readReview
In one paragraph

Review in RSC medicinal chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Review
  3. Metformin-loaded J-AuPPS for infected diabetic wound treatment.Frontiers in bioengineering and biotechnology · 2026
    Article
  4. Review
  5. A NHScientific reports · 2024
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yiwei LiuKey Laboratory of Research and Development of New Medical Materials of Guangdong Medical University, School of Pharmacy, Guangdong Medical University Dongguan 523808 China jianqiangliu8@gdmu.edu.cn +86 769 22896560 +86 769 22896560.
Luyi ZhouKey Laboratory of Research and Development of New Medical Materials of Guangdong Medical University, School of Pharmacy, Guangdong Medical University Dongguan 523808 China jianqiangliu8@gdmu.edu.cn +86 769 22896560 +86 769 22896560.
Ying DongKey Laboratory of Research and Development of New Medical Materials of Guangdong Medical University, School of Pharmacy, Guangdong Medical University Dongguan 523808 China jianqiangliu8@gdmu.edu.cn +86 769 22896560 +86 769 22896560.
Rui WangKey Laboratory of Research and Development of New Medical Materials of Guangdong Medical University, School of Pharmacy, Guangdong Medical University Dongguan 523808 China jianqiangliu8@gdmu.edu.cn +86 769 22896560 +86 769 22896560.
Ying PanKey Laboratory of Research and Development of New Medical Materials of Guangdong Medical University, School of Pharmacy, Guangdong Medical University Dongguan 523808 China jianqiangliu8@gdmu.edu.cn +86 769 22896560 +86 769 22896560.
Shuze ZhuangDongguan Sixth People's Hospital No. 216 Dongcheng West Road, Guancheng District Dongguan 523808 China 405907577@qq.com.
Dong LiuShenzhen Huachuang Biopharmaceutical Technology Co. Ltd. Shenzhen 518112 Guangdong China.
Jianqiang LiuKey Laboratory of Research and Development of New Medical Materials of Guangdong Medical University, School of Pharmacy, Guangdong Medical University Dongguan 523808 China jianqiangliu8@gdmu.edu.cn +86 769 22896560 +86 769 22896560.ORCID https://orcid.org/0000-0002-0553-7937

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With increasing pathogenic bacterial infection that is occurring worldwide, antibacterial therapy has become an important research field. There is great antimicrobial potential in the nanomaterial-based metal-organic framework (MOF) platform because it is highly biocompatible, biodegradable, and nontoxic, and it is now widely used in the anticancer agent industry and in the production of medical products. This review summarizes the possible mechanisms of representative MOF-based nanomaterials, and recounts recent progress in the design and development of MOF-based antibacterial materials for the remedy of postoperative infection. The existing shortcomings and future perspectives of the rapidly growing field of antimicrobial therapy addressing patient quality of life issues are also briefly discussed. Because of their wide applicability, further studies on the use of different MOF antimicrobial therapies will be of great interest.

Identifiers

PMID34223159
PMCPMC8221260

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.